A comprehensive view of Pregnancy Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers
Published: May 08, 2024 by Merck & Co. Inc.
Biden-Harris Administration invests US$105.0M in community-based organizations to improve maternal and infant health in the US; Healthy Start program addresses needs in communities with infant mortality rates 1.5 times the national average or greater
Published: April 29, 2024 by U.S. Dept. of Health and Human Services (HHS)
Labcorp to acquire selected assets of BioReference Health from OPKO Health focused on clinical diagnostics and reproductive and women's health in the US outside of New York and New Jersey for US$237.5M; acquisition expected to close in H2 2024
Published: March 28, 2024 by Laboratory Corp. of America Holdings (LabCorp)
FDA grants Fast Track designation to J&J's nipocalimab injectable for FNAIT treatment, a potentially life-threatening condition affecting pregnant women's immune response to fetal platelets; it is the only therapy in clinical development for the disorder
Published: March 26, 2024 by Janssen Pharmaceutical Companies
Janssen spearheads industry-relevant initiatives, from combatting maternal mortality disparities to promoting health equity in clinical research
Published: March 15, 2024 by Industry Intelligence Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count